Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: A 2-year randomized, placebo-controlled, comparative study

This publication has 23 references indexed in Scilit:

• Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women
  Current Medicinal Chemistry, 2000
• Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women
  American Journal of Obstetrics and Gynecology, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
  Annual Review of Public Health, 1998
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• Uterine perfusion and endometrial thickness in postmenopausal. women on long‐term continuous combined estrogen and progestogen replacement
  Ultrasound in Obstetrics & Gynecology, 1997
• Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: A randomized crossover study
  American Journal of Obstetrics and Gynecology, 1996
• Hormone replacement therapy and endometrial cancer risk: A meta-analysis
  Obstetrics & Gynecology, 1995
• Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women
  Fertility and Sterility, 1992
• Progesterone and estradiol receptors in the cytosol of the human uterine artery
  American Journal of Obstetrics and Gynecology, 1983